S5E44 Geoff Gaw | Nitinol, R&D, and How to Learn About New Technologies

Being an Engineer · 1 Nov 2024 · 47m · Episode 44

What this episode covers

Geoff Gaw, a Senior Principal Engineer at Edwards Lifesciences with prior leadership roles at Medtronic and Applied Medical, discusses the unique challenges of working with Nitinol and managing teams in highly regulated medical device environments. He explains how he aligns product development with process development by waiting for clinical viability signals before committing to mass production strategies, and details his approach to scaling engineering teams by leveraging high performers rather than micromanaging. Gaw also shares his perspective on staying current with emerging technologies through job mobility and predicts the integration of AI in medical procedures, noting the associated risks of opacity in decision-making.

Other shows on the same ground, closest first.

  • Global Medical Device Podcast · 42m

    #337: Moving MedTech Forward - The Past, Present & Future of Greenlight Guru

    David DeRam, CEO of Greenlight Guru, and Pall Johannesson, Managing Director of Greenlight Guru Clinical, discuss the 10-year history of their companies, including the acquisition of Smart Trial. They detail the strategic pivot of Smart Trial, where they discarded months of code to rebuild on robust technology, and the operational challenges of transitioning to remote work during the COVID-19 pandemic. The conversation highlights the company's focus on 'alligator blood' resilience, regulatory navigation like EU MDR, and the integration of AI into their quality management and clinical data platforms.

  • Additive Snack · 1h 02m

    When Production Overtakes Prototyping: Materialise’s Next Phase of AM

    Bart van der Schuren, CTO of Materialise, explains how the company transitioned from a 1995 service bureau to a production powerhouse, recently surpassing prototyping with serial manufacturing. He details the three pillars of Materialise—manufacturing, software, and medical applications—and highlights rapid adoption in hearing aids, dental, and drones, contrasted with the slow, recertification-heavy aerospace sector. Van der Schuren argues that AI-driven automation and in-situ quality control are critical for reducing New Product Introduction (NPI) costs and scaling production in regulated industries.

  • Global Medical Device Podcast · 33m

    #415: Neurotech: Accelerating Innovation in a Complex Medical Device Vertical

    Matt Stratton, Director and Principal Consultant at Coalition, discusses the broad scope of neurotechnology and the challenges of accelerating innovation in this highly regulated vertical. He highlights the difficulty of cross-functional collaboration between neuroscientists, engineers, and regulatory experts, as well as the need for a unified industry voice to navigate complex regulatory frameworks and ethical considerations. Stratton emphasizes the importance of community building to share best practices on funding, clinical trials, and regulatory strategy, drawing parallels to the rapid innovation cycles seen in the semiconductor industry.

  • The Builder Circle · 1h 13m

    S3 E5: AI in Hardware: The Future of Design, Manufacturing, and Innovation with Kristen Edwards

    Kristen Edwards, CTO and co-founder of Pensa Technologies and MIT PhD candidate, discusses integrating AI into hardware engineering workflows, emphasizing the need to track decision reasoning and manage data governance. She explains that while AI acts as a 'co-pilot' to augment human expertise, high-consequence tasks require human oversight due to liability and explainability concerns. Edwards highlights specific challenges in spatial reasoning, design-for-manufacturing translation, and IP security, suggesting techniques like federated learning and retrieval-augmented generation to protect sensitive engineering data. The conversation covers practical applications in CAD, automated testing, and quality assurance, noting that AI will likely replace repetitive tasks rather than creative engineering roles.

  • Let's Combinate · 35m

    126 - Combination Products Collaboration, Turnover on MedTech/Pharma Project Teams, and Lessons from working with Intel's CEO with Mat Stratton, Founder of Coalition Ltd

    Mat Stratton, Founder of Coalition Ltd, discusses his 20-year career in MedTech and combination products, highlighting his early work with Intel CEO Andy Grove on deep brain stimulation and drug delivery systems. He explains how the high-speed culture of Intel, driven by Grove's Parkinson's disease advocacy, contrasted with the slow 4-10 year cycles of medical device development. Stratton identifies 'multifunctional collaboration' and employee turnover as key bottlenecks, proposing solutions like 'two-pizza teams' and regulatory stewardship to accelerate progress in highly regulated industries.

The summary, chapters and topics are generated from the episode’s audio by this directory, not written by Being an Engineer. The episode itself belongs to its publisher.